Loading…
HOT LEMON COLD RELIEF is a brand name for Phenylephrine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the relief of sinus pain and congestion and the symptoms of cold and influenza including headache, sore throat and “feverishness”.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults, including the elderly and children over 12 years of age:
One sachet up to four times daily. Dissolve the contents of one sachet in a tumbler of hot (not boiling) water. Stir well. Add cold water as necessary and sugar if desired. Not more than four sachets to be taken in 24 hours. The dose should not be repeated more frequently than every four hours.
Do not take continuously for more than 3 days without medical advice.
Children under 12 years:
Not recommended for children under 12 years of age except on medical advice.
Undesirable effects Paracetamol Adverse events from historical clinical trial data are both infrequent and from small patient exposure. Accordingly, events reported from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are tabulated below by system class.
Due to limited clinical trial data, the frequency of these adverse events is not known (cannot be estimated from available data), but post-marketing experience indicates that adverse reactions to paracetamol are rare and serious reactions are very rare.
Body System Undesirable effect Blood and lymphatic system disorders Thrombocytopenia Agranulocytosis These are not necessarily causally related to paracetamol Metabolism and nutrition disorders High anion gap metabolic acidosis Immune system disorders Anaphylaxis Cutaneous hypersensitivity reactions including skin rashes, angioedema and Stevens Johnson syndrome/toxic epidermal necrolysis.
Respiratory, thoracic and mediastinal disorders Bronchospasm* Hepatobiliary disorders Hepatic dysfunction *There have been cases of bronchospasm with paracetamol but these are more likely in asthmatics sensitive to aspiring or other NSAIDs.
Phenylephrine hydrochloride The following adverse events have been observed in clinical trials with phenylephrine and may therefore represent the most commonly occurring adverse events. Body System Undesirable effect Psychiatric disorders Nervousness, irritability, restlessness, and excitability Nervous system disorders Headache, dizziness, insomnia Cardiac disorders Increased blood pressure Gastrointestinal disorders Nausea, vomiting Adverse reactions identified during post-marketing use are listed below.
The frequency of these reactions is unknown but likely to be rare. g. rash, urticaria, allergic dermatitis). Hypersensitivity reactions – including that cross-sensitivity may occur with other sympathomimetics Renal and urinary disorders Dysuria, urinary retention.
Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease. g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin.
If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended. The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors.
g. Raynaud’s Phenomenon) This product should not be used by patients taking other sympathomimetics (such as decongestants, appetite suppressants and amphetamine-like psychostimulants). Patients with rare hereditary problems of fructose intolerance, glucose- galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Contains sucrose. This should be taken into account in patients with diabetes. This product contains a source of phenylalanine. May be harmful for people with phenylketonuria. 3mmol of sodium per dose. To be taken into consideration by patients on a sodium controlled diet.
Do not to exceed the stated dose. Patients should be advised not to take with any other paracetamol-containing or any other cold, flu or decongestant products concurrently. Immediate medical advice should be sought in the event of an overdose, even if the patient feels well, because of the risk of delayed, serious liver damage.
If symptoms persist consult your doctor. Keep out of the sight and reach of children.
Hypersensitivity to the active substance or to any of the excipients. Concomitant use of other sympathomimetic decongestants. Phaeochromocytoma. Closed angle glaucoma. 5). Hepatic or renal impairment, diabetes, hyperthyroidism and cardiovascular disease.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Phenylephrine in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
This is most likely to occur in those with bladder outlet obstruction, such as prostatic hypertrophy. 4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
+3 more